Search results
Study: The route into the cell influences the outcome of SARS-CoV-2 infection
Medical Xpress· 4 days agoThis TMPRSS2-mediated uptake significantly alters the immune response of the host cells and drives the evolution of the virus. The team also showed that ...
Researchers take step toward development of universal COVID-19 antibodies
telegraphherald.com· 5 days agoSARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine ...
Invivyd appoints new Chief Commercial Officer ahead of PEMGARDA launch By Investing.com
Investing.com· 4 days agoLee's extensive experience in the pharmaceutical industry is expected to enhance the company's...
Levels of COVID in Mass. wastewater tick up with arrival of new ‘FLiRT’ variants - The Boston Globe
The Boston Globe· 6 days agoDoron called the increase “very, very, very gradual.” “Certainly it’s nothing like when Omicron was...
Hawaii sees COVID-19 positivity uptick amid variant spread
Tribune via AOL· 6 days agoMay 29—1/1 Swipe or click to see more STAR-ADVERTISER An intake specialist works on testing samples for COVID-19 at Honolulu airport in August 2022. The ...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 5 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
COVID patients at higher risk for respiratory complications well after infection, study finds
Center for Infectious Disease Research and Policy· 7 days agoThe risks of respiratory complications were eightfold and nearly twofold greater in COVID-19...
Covid will still be here this summer. Will anyone care?
Washington Post via Yahoo News· 4 days agoCorrection: A previous version of this article said the CDC revised its covid quarantine protocols...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 4 hours agoGHENT, Belgium, June 04, 2024 (GLOBE NEWSWIRE) -- ExeVir Bio, a biotech company developing robust heavy chain-only antibody therapies for broad protection against infectious diseases, today announced new data demonstrating that its antibodies
Fauci testifies publicly before House panel on COVID origins, controversies
WUSA 9 Washington, D.C.· 20 hours agoDr. Anthony Fauci, the top U.S. infectious disease expert until leaving the government in 2022,...